US Venture Partners — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inMudit Jain(Executive Officer, Director)in
Board seatCasey Tansey· per SEC Form D
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.
BiotechHardwareHealthtechMedical DevicesSan Mateo, US
Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)inDr. Joey English(Chief Medical Officer)Tony Chou(Founder)in
BoardJack Lasersohn(Director)inTamir Meiri(Director)
Co-investorsNovo HoldingsThe Vertical GroupNorwest Venture PartnersRunway Growth CapitalSectoral Asset ManagementSofinnova Ventures+1 more
Stream Security provides a cloud security investigation tool that correlates detection signals with real-time cloud context — including identity activity, network flows, Kubernetes logs, data sensitivity, and inputs from existing tools like EDR — into a single stateful view.
AI & Machine LearningCloud ComputingCybersecuritySaaSTel Aviv, IL
Or Shoshani(Founder)inStav Sitnikov(Founder)inLiran Roffman(Founder)inOr Shoshani Stav Sitnikov(Founder)
Co-investorsCervinEnergy Impact PartnersGlilot Capital PartnersTLV PartnersCERVIN VENTURESCiti Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






















